| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2024―Okt―04 |
Corrigendum to “Increased adrenal steroidogenesis and suppressed corticosteroid responsiveness in critical COVID-19” [Metabolism volume 160 (2024) 155980] |
Tian-Zi Wen, Tian-Ran Li, Xin-Yu Chen, He-Yuan Chen, Shuai Wang, Wen-Juan Fu, Shi-Qi Xiao, Jie Luo, Jia-Feng Huang, Rui Tang, Zhi-Cheng He, Tao Luo, Hong-Liang Zhao, Cong Chen, Jing-Ya Miao, Qin Niu, Yan Wang, Xiu-Wu Bian, Xiao-Hong Yao |
| 2 |
[GO] |
2024―Jul―23 |
Increased adrenal steroidogenesis and suppressed corticosteroid responsiveness in critical COVID-19 |
Tian-Zi Wen, Tian-Ran Li, Xin-Yu Chen, He-Yuan Chen, Shuai Wang, Wen-Juan Fu, Shi-Qi Xiao, Jie Luo, Rui Tang, Jia-Le Ji, Jia-Feng Huang, Zhi-Cheng He, Tao Luo, Hong-Liang Zhao, Cong Chen, Jing-Ya Miao, Qin Niu, Yan Wang, Xiu-Wu Bian, Xiao-Hong Yao |
| 3 |
[GO] |
2024―Jun―15 |
Diabetics and Insulin Resistant Patients, Especially Post COVID-19, Have an Increased Biologic Age From Analysis of Brain FDG PET |
H.T. Pretorius, G.M. Hubbell, B. Budke, N.M. Bodnar, B. Murray, B.M. Brosal, D. Menke |
| 4 |
[GO] |
2024―Apr―18 |
Virus-induced diabetes mellitus, revisiting infection etiology in light of SARS-CoV-2 |
Sundararaj Stanleyraj Jeremiah, Abu Saleh Md Moin, Alexandra E. Butler |
| 5 |
[GO] |
2024―Feb―13 |
Mortality risk in patients with obesity and COVID-19 infection: a systematic review and meta-analysis |
Haber Rachelle, Ghezzawi Malak, Puzantian Houry, Haber Marc, Saad Sacha, Ghandour Yara, El Bachour Joseph, Yazbeck Anthony, Hassanieh Ghinwa, Mehdi Celine, Ismail Dima, Abi-Kharma Elias, El-Zein Ola, Khamis Assem, Chakhtoura Marlene, Mantzoros Christos |
| 6 |
[GO] |
2023―Nov―01 |
Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity |
Takahiro Fukushima, Tomoki Maetani, Shotaro Chubachi, Naoya Tanabe, Takanori Asakura, Ho Namkoong, Hiromu Tanaka, Takashi Shimada, Shuhei Azekawa, Shiro Otake, Kensuke Nakagawara, Mayuko Watase, Yusuke Shiraishi, Hideki Terai, Mamoru Sasaki, Soichiro Ueda, Yukari Kato, Norihiro Harada, Shoji Suzuki, Shuichi Yoshida, Hiroki Tateno, Yoshitake Yamada, Masahiro Jinzaki, Toyohiro Hirai, Yukinori Okada, Ryuji Koike, Makoto Ishii, Akinori Kimura, Seiya Imoto, Satoru Miyano, Seishi Ogawa, Takanori Kanai, Koichi Fukunaga |
| 7 |
[GO] |
2023―Mai―09 |
Analysis of Cardiovascular Complications during Delivery Admissions Associated with COVID-19 |
Salman Zahid, Ankit Agrawal, Devesh Rai, Muhammad Zia Khan, Erin D. Michos |
| 8 |
[GO] |
2023―Mai―09 |
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History |
Cesar Ochoa, Nallely Dolores Guerra Olivares, Roxana del Socorro González Dzib, Tania M. Peña Arriaga |
| 9 |
[GO] |
2023―Mai―09 |
Outcome of Cardiovascular Diseases in Covid-19 Patients in a Tertiary Care Hospital in South India |
Judah Rajendran, Shivani Ravichandran, Mathan Karthik m, Nayyar Iqbal |
| 10 |
[GO] |
2023―Jan―31 |
Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort |
Gaborit Bénédicte, Fernandes Sara, Loubet Paul, Ninove Laetitia, Dutour Anne, Cariou Bertrand, Coupaye Muriel, Clement Karine, Czernichow Sébastien, Carette Claire, Resseguier Noémie, Esterle Laure, Sabrina Kali, Marie Houssays, de Lamballerie Xavier, Wittkop Linda, Launay Odile, Laville Martine |
| 11 |
[GO] |
2022―Okt―08 |
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis |
Honghao Lai, Manli Yang, Mingyao Sun, Bei Pan, Quan Wang, Jing Wang, Jinhui Tian, Guowu Ding, Kehu Yang, Xuping Song, Long Ge |
| 12 |
[GO] |
2022―Jul―25 |
Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection |
Theodoros Kelesidis, Christos S. Mantzoros |
| 13 |
[GO] |
2022―Jun―08 |
SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1 |
Jihoon Shin, Shinichiro Toyoda, Shigeki Nishitani, Toshiharu Onodera, Shiro Fukuda, Shunbun Kita, Atsunori Fukuhara, Iichiro Shimomura |
| 14 |
[GO] |
2022―Mai―26 |
COVID-19 and sulfonylureas: A reminder of the pleiotropic actions of an old class of drugs just before their swansong |
Theocharis Koufakis, Djordje S. Popovic, Symeon Metallidis, Kalliopi Kotsa |
| 15 |
[GO] |
2022―Mai―15 |
A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on |
Chrysoula Boutari, Christos S. Mantzoros |
| 16 |
[GO] |
2022―Apr―02 |
Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients |
Helena Castañé, Simona Iftimie, Gerard Baiges-Gaya, Elisabet Rodríguez-Tomàs, Andrea Jiménez-Franco, Ana Felisa López-Azcona, Pedro Garrido, Antoni Castro, Jordi Camps, Jorge Joven |
| 17 |
[GO] |
2022―Apr―01 |
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis |
Nam Nhat Nguyen, Dung Si Ho, Hung Song Nguyen, Dang Khanh Ngan Ho, Hung-Yuan Li, Chia-Yuan Lin, Hsiao-Yean Chiu, Yang-Ching Chen |
| 18 |
[GO] |
2022―Mrz―18 |
Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity |
Kang Du, Ling Sun, Zichen Luo, Yang Cao, Qiushi Sun, Kangzhen Zhang, Ahmed Faizy, Daniele Piomelli, Xiang Lu, Jinjun Shan, Qin Yang |
| 19 |
[GO] |
2022―Mrz―03 |
Cardio-metabolic factors associated to mortality in patients with COVID-19 |
Camey Eduardo, Arauz Guillermo, Cárcamo Alejandra, Celis Grecia |
| 20 |
[GO] |
2022―Mrz―03 |
COVID-19 and metabolic syndrome |
H. Chaabouni, F. Smaoui, K. Mnif, K. Rekik, C. Marrakchi, M. Koubaa, M. Ben Jemaa |
| 21 |
[GO] |
2022―Mrz―03 |
Influence of metabolic syndrome components in the course of covid-19 in patients with nonalcoholic fatty liver disease |
Guzal Naimovna Sobirova, Zarnigor Orifovna Bafoeva, Mirvasit Mirvasikovich Karimov |
| 22 |
[GO] |
2022―Mrz―03 |
Challenges of diabetes management during COVID-19 infection |
H. Chaabouni, F. Smaoui, K. Mnif, K. Rekik, C. Marrakchi, M. Koubaa, M. Ben Jemaa |
| 23 |
[GO] |
2022―Mrz―03 |
Impact of COVID-19 outbreak in health care of people with type 2 diabetes: evidence from a cross-sectional study in Albania |
Fatjona Kamberi, Jerina Jaho, Enkeleda Sinaj, Vjollca Ndreu, Ilirjana Zekja |
| 24 |
[GO] |
2022―Mrz―03 |
Gestational Diabetes Mellitus: increased incidence during the COVID-19 pandemic |
Hala Boutrid, Nada Boutrid, S. Chaat, M. Keghouche, H. Rahmoune, F. Madaci |
| 25 |
[GO] |
2022―Mrz―03 |
Challenges for Effective Glycemic control in T2DM during Covid-19 pandemic and Use of Glimepiride/Metformin FDC: Opinion from Indian Clinicians |
Alka Gandhi, C.R. Anand Moses, Nilesh Detroja, Ajay Ajmani, Mahesh Abhyankar |
| 26 |
[GO] |
2022―Mrz―03 |
New onset Diabetes Mellitus in a COVID-19 patient: A Case report |
Karam R. Motawea, Kirellos Said Abbas, Yossef Hassan AbdelQadir, Fatma A. Monib |
| 27 |
[GO] |
2022―Mrz―03 |
The impact of chronic kidney disease in diabetic COVID-19 patients |
Hana Chaabouni, Ichrak Bougharriou, Khouloud Mnif, Majdi Maazoun, Tarak Ben Jemaa, Khaoula Rekik, Fatma Smaoui, Makram Koubaa, Chakib Marrakchi, Boussayma Hammami, Mounir Ben Jemaa |
| 28 |
[GO] |
2022―Mrz―03 |
COVID-19 related morbidity and mortality among patients with diabetes |
H. Chaabouni, F. Smaoui, K. Mnif, K. Rekik, C. Marrakchi, M. Koubaa, M. Ben Jemaa |
| 29 |
[GO] |
2022―Mrz―03 |
The influence of metformin on the rate of Covid-19 vaccination among diabetes type 2 patients in Poland |
Daniel Bałut, Marcin Kleibert, Patrycja Małgorzata Bąk, Jakub Zieliński, Beata Mrozikiewicz-Rakowska |
| 30 |
[GO] |
2022―Mrz―03 |
Diet-induced obesity and NASH aggravate SARS-CoV-2 infection in golden Syrian hamsters |
François Briand, Valentin Sencio, Thierry Sulpice, François Trottein |
| 31 |
[GO] |
2022―Jan―29 |
Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients |
Hui-Qi Qu, Jingchun Qu, Joseph Glessner, Hakon Hakonarson |
| 32 |
[GO] |
2022―Jan―10 |
Editorial: Obesity, metabolic phenotypes and COVID-19 |
Despina Sanoudou, Michael A. Hill, Matthew J. Belanger, Kevin Arao, Christos S. Mantzoros |
| 33 |
[GO] |
2021―Okt―27 |
Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry |
Matt Spick, Holly M. Lewis, Michael J. Wilde, Christopher Hopley, Jim Huggett, Melanie J. Bailey |
| 34 |
[GO] |
2021―Sep―30 |
Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity |
Nam Hoon Kim, Kyeong Jin Kim, Jimi Choi, Sin Gon Kim |
| 35 |
[GO] |
2021―Aug―05 |
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19 |
Stefania L. Calvisi, Giuseppe A. Ramirez, Marina Scavini, Valentina Da Prat, Giuseppe Di Lucca, Andrea Laurenzi, Gabriele Gallina, Ludovica Cavallo, Giorgia Borio, Federica Farolfi, Maria Pascali, Jacopo Castellani, Vito Lampasona, Armando D'Angelo, Giovanni Landoni, Fabio Ciceri, Patrizia Rovere Querini, Moreno Tresoldi, Lorenzo Piemonti |
| 36 |
[GO] |
2021―Jul―30 |
Diabetic ketoacidosis in pediatric patients with type1- and type2 diabetes during the COVID-19 pandemic |
Charlotte Loh, Paul Weihe, Nicole Kuplin, Kerstin Placzek, Susann Weihrauch-Blüher |
| 37 |
[GO] |
2021―Jun―29 |
Obesity and COVID-19 mortality |
Yadong Wang, Jie Xu, Ying Wang, Hongjie Hou, Huifen Feng, Haiyan Yang |
| 38 |
[GO] |
2021―Jun―11 |
Diabetes and COVID-19: The Past, The Present, and The Future |
Raymond Pranata, Joshua Henrina, Wilson Matthew Raffaello, Sherly Lawrensia, Ian Huang |
| 39 |
[GO] |
2021―Mrz―26 |
COVID-19 Editorial: Mechanistic Links and Daunting Therapeutic Challenges for Metabolic Diseases One Year after The Beginning of The COVID-19 Pandemic |
Christopher M. Tessier, Alexander Kokkinos, Geltrude Mingrone, Chrysi Koliaki, Juleen R. Zierath, Christos S. Mantzoros |
| 40 |
[GO] |
2021―Mrz―24 |
The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis |
Aya Bassatne, Maya Basbous, Marlene Chakhtoura, Ola El Zein, Maya Rahme, Ghada El-Hajj Fuleihan |
| 41 |
[GO] |
2021―Mrz―02 |
The serum metabolome of COVID-19 patients is distinctive and predictive |
Ding Shi, Ren Yan, Longxian Lv, Huiyong Jiang, Yingfeng Lu, Jifang Sheng, Jiaojiao Xie, Wenrui Wu, Jiafeng Xia, Kaijin Xu, Silan Gu, Yanfei Chen, Chenjie Huang, Jing Guo, Yiling Du, Lanjuan Li |
| 42 |
[GO] |
2021―Feb―23 |
Impact of body composition on COVID-19 susceptibility and severity: a two-sample multivariable Mendelian randomization study |
Dennis Freuer, Jakob Linseisen, Christa Meisinger |
| 43 |
[GO] |
2021―Feb―04 |
COVID-19 letter to the editor: Epicardial fat inflammation as possible enhancer in COVID-19? |
Yuhao Zhao, Mulei Chen, Xinchun Yang, Lei Zhao |
| 44 |
[GO] |
2021―Jan―29 |
Improving Glycemic Control in Patients With COVID-19 : A Quality Improvement Project |
N.A. Jadoon, S. Noor, M. Iqbal, N. Pervez |
| 45 |
[GO] |
2021―Jan―29 |
Remote Monitoring of Pregnancies Complicated by Gestational Diabetes Mellitus during the COVID-19 : Lockdown Using STORK |
Christos Chatzakis, Dimitrios Floros, Nikolaos Pitsianis, Alexandros Sotiriadis |
| 46 |
[GO] |
2021―Jan―29 |
Continuous Blood Glucose Monitoring to Determine Glycemic Variability in Patients Having COVID-19 Infection and Its Bearing on the Severity of the Disease |
Archit Jain, Jitendra D. Lakhani, Hetal Pandya |
| 47 |
[GO] |
2021―Jan―29 |
Systematic Review and Meta-Analysis of the Observational Trials Evaluating the Functional Impact of COVID-19 on Sexual Health |
Deepak Jumani, Abhishek Jumani, Shashank Joshi, Ghufran Lufti Ismaeel |
| 48 |
[GO] |
2021―Jan―29 |
Association Between BMI and Food Quality in Adults During COVID-19 Pandemic, Albania |
Brunilda Subashi, Kristela Jaupaj, Jerina Jaho, Llambi Subashi, Indrita Fejzaj, Ina Shuaipi |
| 49 |
[GO] |
2021―Jan―29 |
Worry Perception of the COVID-19 Pandemic in Children and Adolescents with Type 1 Diabetes |
Nouran Y. Salah, Amal Y. Abido, Hebatallah R. Rashed |
| 50 |
[GO] |
2021―Jan―29 |
A Telemedicine Approach For Assessment, Empowerment And Triage For COVID-19 Patients with Comorbidities |
Bijay Patni |
| 51 |
[GO] |
2021―Jan―07 |
Excess body weight is an independent risk factor for severe forms of COVID-19 |
Léa Pietri, Roch Giorgi, Audrey Bégu, Manon Lojou, Marie Koubi, Raphael Cauchois, Rachel Grangeot, Noémie Dubois, Gilles Kaplanski, René Valéro, Sophie Béliard |
| 52 |
[GO] |
2020―Dez―07 |
Reply to Vitamin D deficiency in COVID-19: mixing up cause and consequence |
M. Chakhtoura, G. El Hajj Fuleihan |
| 53 |
[GO] |
2020―Nov―25 |
visceral fat is associated to the severity of COVID-19 |
Guillaume Favre, Kevin Legueult, Christian Pradier, Charles Raffaelli, Carole Ichai, Antonio Iannelli, Alban Redheuil, Olivier Lucidarme, Vincent Esnault |
| 54 |
[GO] |
2020―Nov―20 |
Epicardial adipose tissue is associated with extent of pneumonia and adverse outcomes in patients with COVID-19 |
Kajetan Grodecki, Andrew Lin, Aryabod Razipour, Sebastien Cadet, Priscilla A. McElhinney, Cato Chan, Barry D. Pressman, Peter Julien, Pal Maurovich-Horvat, Nicola Gaibazzi, Udit Thakur, Elisabetta Mancini, Cecilia Agalbato, Robert Menè, Gianfranco Parati, Franco Cernigliaro, Nitesh Nerlekar, Camilla Torlasco, Gianluca Pontone, Piotr J. Slomka, Damini Dey |
| 55 |
[GO] |
2020―Nov―19 |
Obesity, Diabetes, Non-alcoholic Fatty Liver Disease and Metabolic Dysfunction Associated Fatty Liver Disease are Proinflammatory Hypercoagulable States associated with Severe Disease and Thrombosis in Covid-19 |
Dong Ji, Mingjie Zhang, Enqiang Qin, Lunqing Zhang, Jing Xu, Yudong Wang, Gregory Cheng, Feng Wang, George Lau |
| 56 |
[GO] |
2020―Nov―17 |
Letter to the editor: vitamin D deficiency in COVID-19: mixing up cause and consequence |
Joost Smolders, Jody van den Ouweland, Christopher Geven, Peter Pickkers, Mathijs Kox |
| 57 |
[GO] |
2020―Nov―04 |
Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: biomarker response to hypoglycemia |
Abu Saleh Md Moin, Ahmed Al-Qaissi, Thozhukat Sathyapalan, Stephen L. Atkin, Alexandra E. Butler |
| 58 |
[GO] |
2020―Okt―17 |
Mediterranean diet as a nutritional approach for COVID-19 |
Angeliki M. Angelidi, Alexander Kokkinos, Eleftheria Katechaki, Emilio Ros, Christos S. Mantzoros |
| 59 |
[GO] |
2020―Okt―17 |
Commentary: COVID-19 and Obesity Pandemics Converge into a Syndemic Requiring Urgent and Multidisciplinary Action |
Michael A. Hill, James R. Sowers, Christos S. Mantzoros |
| 60 |
[GO] |
2020―Okt―13 |
Metabolic impact of weight loss induced reduction of adipose ACE-2 - Potential implication in COVID-19 infections? |
Linna Li, Leonard Spranger, Dominik Soll, Finja Beer, Maria Brachs, Joachim Spranger, Knut Mai |
| 61 |
[GO] |
2020―Sep―28 |
Obesity in patients with COVID-19: a systematic review and meta-analysis |
Yi HUANG, L.U. Yao, Yan-Mei HUANG, Min WANG, Wei LING, Yi SUI, Hai-Lu ZHAO |
| 62 |
[GO] |
2020―Sep―23 |
Statins, COVID-19, and coronary artery disease: killing two birds with one stone |
Shiva Ganjali, Vanessa Bianconi, Peter E. Penson, Matteo Pirro, Maciej Banach, Gerald F. Watts, Amirhossein Sahebkar |
| 63 |
[GO] |
2020―Sep―16 |
Association of Body mass index (BMI) with Critical COVID-19 and in-hospital Mortality: a dose-response meta-analysis |
Yanbin Du, Yuan Lv, Wenting Zha, Nan Zhou, Xiuqin Hong |
| 64 |
[GO] |
2020―Aug―22 |
Obesity & genetic predisposition with COVID-19 |
Zhaozhong Zhu, Kohei Hasegawa, Baoshan Ma, Michimasa Fujiogi, Carlos A. Camargo, Liming Liang |
| 65 |
[GO] |
2020―Aug―22 |
Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: population-based, prospective cohort study |
Mark Hamer, Catharine R. Gale, G. David Batty |
| 66 |
[GO] |
2020―Jul―23 |
Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID-19 |
Mikiko Watanabe, Damiano Caruso, Dario Tuccinardi, Renata Risi, Marta Zerunian, Michela Polici, Francesco Pucciarelli, Mariarita Tarallo, Lidia Strigari, Silvia Manfrini, Stefania Mariani, Sabrina Basciani, Carla Lubrano, Andrea Laghi, Lucio Gnessi |
| 67 |
[GO] |
2020―Jul―23 |
Commentary. Eliminating Vitamin D Deficiency During the COVID-19 Pandemic: A Call to Action |
JoAnn E. Manson, Shari S. Bassuk |
| 68 |
[GO] |
2020―Jul―14 |
Commentary: COVID-19 and Obesity: Exploring Biologic Vulnerabilities, Structural Disparities, and Weight Stigma |
Matthew J. Townsend, Theodore K. Kyle, Fatima C. Stanford |
| 69 |
[GO] |
2020―Jul―14 |
The role of visceral adiposity in the severity of COVID-19: highlights from a unicenter cross-sectional pilot study in Germany |
Antonia Petersen, Keno Bressem, Jakob Albrecht, Hans-Martin Thieß, Janis Vahldiek, Bernd Hamm, Marcus R. Makowski, Alexandra Niehues, Stefan Niehues, Lisa C. Adams |
| 70 |
[GO] |
2020―Jun―24 |
Unexpected high mortality in COVID-19 and diabetic ketoacidosis |
Natalia Chamorro-Pareja, Sahana Parthasarathy, Jayabhargav Annam, Julie Hoffman, Christine Coyle, Preeti Kishore |
| 71 |
[GO] |
2020―Jun―21 |
Letter to the editor: Immunomodulation by phsphodiesterase-4 inhibitor in COVID-19 patients |
Alessandro Santaniello, Barbara Vigone, Lorenzo Beretta |
| 72 |
[GO] |
2020―Jun―01 |
Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19 |
Maria Dalamaga, Irene Karampela, Christos S. Mantzoros |
| 73 |
[GO] |
2020―Mai―26 |
Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic |
M. Chakhtoura, N. Napoli, G. El Hajj Fuleihan |
| 74 |
[GO] |
2020―Mai―16 |
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York |
Leonidas Palaiodimos, Damianos G. Kokkinidis, Weijia Li, Dimitrios Karamanis, Jennifer Ognibene, Shitij Arora, William N. Southern, Christos S. Mantzoros |
| 75 |
[GO] |
2020―Mai―08 |
Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens? |
Maria Dalamaga, Irene Karampela, Christos S. Mantzoros |
| 76 |
[GO] |
2020―Apr―30 |
The first Ramadan during COVID-19 pandemic: 1.8 billion Muslims should fast or not? |
Saeedeh Mosaferchi, Ehsan Sharif-Paghaleh, Alireza Mortezapour, Rashid Heidarimoghadam |
| 77 |
[GO] |
2020―Apr―29 |
Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease |
Abdulzahra Hussain, Peter Vasas, Shamsi EL-Hasani |
| 78 |
[GO] |
2020―Apr―28 |
Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy |
Casey Means |
| 79 |
[GO] |
2020―Apr―27 |
Testosterone, a key hormone in the context of COVID-19 pandemic |
Paolo Pozzilli, Andrea Lenzi |
| 80 |
[GO] |
2020―Apr―27 |
Obesity: The “Achilles heel” for COVID-19? |
Giovanna Muscogiuri, Gabriella Pugliese, Luigi Barrea, Silvia Savastano, Annamaria Colao |
| 81 |
[GO] |
2020―Apr―24 |
Mental Health and Psychological Distress in People with Diabetes during COVID-19 |
Sonia Mukhtazr, Sakina Mukhtar |
| 82 |
[GO] |
2020―Apr―23 |
Obesity hypoventilation syndrome and severe COVID-19 |
Jiao-Feng Huang, Xiao-Bo Wang, Kenneth I. Zheng, Wen-Yue Liu, Jun-Jie Chen, Jacob George, Ming-Hua Zheng |
| 83 |
[GO] |
2020―Apr―23 |
Importance of metabolic health in the era of COVID-19 |
Eleni Rebelos, Diego Moriconi, Agostino Virdis, Stefano Taddei, Diego Foschi, Monica Nannipieri |
| 84 |
[GO] |
2020―Apr―19 |
COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next |
Angeliki M. Angelidi, Matthew J. Belanger, Christos S. Mantzoros |
| 85 |
[GO] |
2020―Apr―19 |
Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease |
Kenneth I. Zheng, Feng Gao, Xiao-Bo Wang, Qing-Feng Sun, Ke-Hua Pan, Ting-Yao Wang, Hong-Lei Ma, Wen-Yue Liu, Jacob George, Ming-Hua Zheng |
| 86 |
[GO] |
2020―Apr―19 |
Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019 |
Junli Fan, Hui Wang, Guangming Ye, Xiaoling Cao, Xianqun Xu, Wenbin Tan, Yongxi Zhang |
| 87 |
[GO] |
2020―Apr―07 |
COVID-19 in patients with diabetes: risk factors that increase morbidity |
David C. Klonoff, Guillermo E. Umpierrez |
| 88 |
[GO] |
2020―Mrz―24 |
Commentary: COVID-19 in Patients with Diabetes |
Michael A. Hill, Christos Mantzoros, James R. Sowers |
| 89 |
[GO] |
2020―Mrz―24 |
Diabetes patients with COVID-19 need better care |
Jun Zhou, Jie Tan |
|
